Xellsmart

Suzhou, China · Founded 2021 · Privately Held (backing)

Developer of stem cell treatment solutions intended to improve major disease treatment and drug discovery. Xellsmart is based in Suzhou, China and was founded in 2021. Its last reported valuation was $158 million in Mar 2023. It has raised $156 million.

Last reported valuation

$158.0M

Oct 2026

Priced at

—

Total raised

$156.1M

Last round

—

How much has Xellsmart raised?

$156.1Macross 0 recorded rounds

Free account

More of Xellsmart with a free account

·The complete investor list: 34 names
·Watch Xellsmart: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Xellsmart investors

34 investors are on record for Xellsmart, including Suzhou Oriza Holdings Corporation, HSG (Hong Kong), Qiming Venture Partners and YuanBio Venture Capital.

For fundraisers

Raising for a company like Xellsmart?

34 investors have backed Xellsmart.

See all 34 investors →

Frequently asked about Xellsmart

How much has Xellsmart raised?: Xellsmart has raised $156.1M in total across 0 recorded funding rounds.